{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T15:21:42Z","timestamp":1769268102484,"version":"3.49.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Vaccine Initiative (ESCP)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.vaccine.2017.02.003","type":"journal-article","created":{"date-parts":[[2017,4,19]],"date-time":"2017-04-19T02:15:32Z","timestamp":1492568132000},"page":"5426-5433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evaluation of immune responses of stabilised SAT2 antigens of foot-and-mouth disease in cattle"],"prefix":"10.1016","volume":"35","author":[{"given":"Katherine A.","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.M.","family":"Rathogwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.V.","family":"Capozzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois F.","family":"Maree","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2017.02.003_b0005","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1865-1682.2007.01016.x","article-title":"Planning for the progressive control of foot-and-mouth disease worldwide","volume":"55","author":"Rweyemamu","year":"2008","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2017.02.003_b0010","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1865-1682.2007.01013.x","article-title":"Epidemiological patterns of foot-and-mouth disease worldwide","volume":"55","author":"Rweyemamu","year":"2008","journal-title":"Transbound Emerg Dis"},{"key":"10.1016\/j.vaccine.2017.02.003_b0015","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1746-6148-6-54","article-title":"The role of African buffalos (Syncerus caffer) in the maintenance of foot-and-mouth disease in Uganda","volume":"6","author":"Ayebazibwe","year":"2010","journal-title":"BMC Vet Res"},{"key":"10.1016\/j.vaccine.2017.02.003_b0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.20506\/rst.21.1.1322","article-title":"Infectious animal diseases: the wildlife\/livestock interface","volume":"21","author":"Bengis","year":"2002","journal-title":"Rev Sci Tech"},{"key":"10.1016\/j.vaccine.2017.02.003_b0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0147-9571(85)90004-9","article-title":"The duration of the foot-and-mouth disease virus carrier state in African buffalo (i) in the individual animal and (ii) in a free-living herd","volume":"8","author":"Condy","year":"1985","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2017.02.003_b0030","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0021-9975(72)90045-X","article-title":"Infection of some species of African wild life with foot-and-mouth disease virus","volume":"82","author":"Hedger","year":"1972","journal-title":"J Comp Pathol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0035","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1099\/0022-1317-77-7-1457","article-title":"Persistent infection of African buffalo (Syncerus caffer) with SAT-type foot-and-mouth disease viruses: rate of fixation of mutations, antigenic change and interspecies transmission","volume":"77","author":"Vosloo","year":"1996","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0040","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1023\/A:1026352000959","article-title":"Molecular epidemiology of SAT3-type foot-and-mouth disease","volume":"27","author":"Bastos","year":"2003","journal-title":"Virus Genes"},{"key":"10.1016\/j.vaccine.2017.02.003_b0045","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1099\/vir.0.18859-0","article-title":"The implications of virus diversity within the SAT 2 serotype for control of foot-and-mouth disease in sub-Saharan Africa","volume":"84","author":"Bastos","year":"2003","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0050","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s007050170077","article-title":"Genetic heterogeneity of SAT-1 type foot-and-mouth disease viruses in southern Africa","volume":"146","author":"Bastos","year":"2001","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0055","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1017\/S0950268899004008","article-title":"Natural transmission of foot-and-mouth disease virus between African buffalo (Syncerus caffer) and impala (Aepyceros melampus) in the Kruger National Park, South Africa","volume":"124","author":"Bastos","year":"2000","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2017.02.003_b0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1136\/vr.134.10.230","article-title":"Natural transmission of foot-and-mouth disease virus from African buffalo (Syncerus caffer) to cattle in a wildlife area of Zimbabwe","volume":"134","author":"Dawe","year":"1994","journal-title":"Vet Rec"},{"key":"10.1016\/j.vaccine.2017.02.003_b0065","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0168-1702(02)00263-0","article-title":"Foot and mouth disease in wildlife","volume":"91","author":"Thomson","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.02.003_b0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF01320790","article-title":"Thermal stability of foot-and-mouth disease virus","volume":"70","author":"Doel","year":"1981","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-1702(02)00261-7","article-title":"FMD vaccines","volume":"91","author":"Doel","year":"2003","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.02.003_b0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0264-410X(97)00170-9","article-title":"Vaccination as a means of control of foot-and-mouth disease in sub-saharan Africa","volume":"16","author":"Hunter","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0085","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1099\/vir.0.032839-0","article-title":"Predicting antigenic sites on the foot-and-mouth disease virus capsid of the South African Territories types using virus neutralization data","volume":"92","author":"Maree","year":"2011","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0090","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.virusres.2010.09.004","article-title":"Introduction of tag epitopes in the inter-AUG region of foot and mouth disease virus: effect on the L protein","volume":"155","author":"Piccone","year":"2011","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.02.003_b0095","doi-asserted-by":"crossref","first-page":"7092","DOI":"10.1128\/JVI.68.11.7092-7098.1994","article-title":"Vaccines prepared from chimeras of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies and protective immunity to multiple serotypes of FMDV","volume":"68","author":"Rieder","year":"1994","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0100","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nsmb.3096","article-title":"Structure-based energetics of protein interfaces guides foot-and-mouth disease virus vaccine design","volume":"22","author":"Kotecha","year":"2015","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0105","doi-asserted-by":"crossref","first-page":"12232","DOI":"10.1128\/JVI.01553-08","article-title":"Engineering viable foot-and-mouth disease viruses with increased thermostability as a step in the development of improved vaccines","volume":"82","author":"Mateo","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0110","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/JVI.64.6.2467-2473.1990","article-title":"Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA","volume":"64","author":"Zibert","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0115","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1016\/j.vaccine.2015.04.058","article-title":"Intra-serotype SAT2 chimeric foot-and-mouth disease vaccine protects cattle against FMDV challenge","volume":"33","author":"Maree","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0120","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.vaccine.2008.02.012","article-title":"Chimeric foot-and-mouth disease viruses: evaluation of their efficacy as potential marker vaccines in cattle","volume":"26","author":"Fowler","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0125","first-page":"119","article-title":"Prospects for the control of foot-and-mouth disease: an African perspective","volume":"5","author":"Maree","year":"2014","journal-title":"J Vet Med"},{"key":"10.1016\/j.vaccine.2017.02.003_b0130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.virusres.2010.07.010","article-title":"Mapping of amino acid residues responsible for adhesion of cell culture-adapted foot-and-mouth disease SAT type viruses","volume":"153","author":"Maree","year":"2010","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.02.003_b0135","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.virusres.2006.11.003","article-title":"A second RGD motif in the 1D capsid protein of a SAT1 type foot-and-mouth disease virus field isolate is not essential for attachment to target cells","volume":"124","author":"Storey","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.02.003_b0140","doi-asserted-by":"crossref","first-page":"41019","DOI":"10.1074\/jbc.M304990200","article-title":"Complete alanine scanning of intersubunit interfaces in a foot-and-mouth disease virus capsid reveals critical contributions of many side chains to particle stability and viral function","volume":"278","author":"Mateo","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2017.02.003_b0145","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/j.1460-2075.1989.tb03541.x","article-title":"Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus","volume":"8","author":"Filman","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2017.02.003_b0150","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1128\/JVI.75.2.952-960.2001","article-title":"Coxsackievirus A9 VP1 mutants with enhanced or hindered A particle formation and decreased infectivity","volume":"75","author":"Airaksinen","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0155","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1099\/vir.0.82521-0","article-title":"Thermostable variants are not generally represented in foot-and-mouth disease virus quasispecies","volume":"88","author":"Mateo","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0160","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/0264-410X(95)00079-G","article-title":"Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines","volume":"13","author":"Twomey","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0165","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0264-410X(96)00284-8","article-title":"Total and isotype humoral responses in cattle vaccinated with foot and mouth disease virus (FMDV) immunogen produced either in bovine tongue tissue or in BHK-21 cell suspension cultures","volume":"15","author":"Capozzo","year":"1997","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0170","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1016\/S0264-410X(03)00219-6","article-title":"Foot-and-mouth disease vaccine potency testing: determination and statistical validation of a model using a serological approach","volume":"21","author":"Barnett","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0175","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.virusres.2012.05.026","article-title":"Mapping of antigenic determinants on a SAT2 foot-and-mouth disease virus using chicken single-chain antibody fragments","volume":"167","author":"Opperman","year":"2012","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2017.02.003_b0180","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1099\/vir.0.19509-0","article-title":"Studies of genetically defined chimeras of a European type A virus and a South African Territories type 2 virus reveal growth determinants for foot-and-mouth disease virus","volume":"85","author":"Van Rensburg","year":"2004","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0185","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/JCM.00510-09","article-title":"Highly sensitive fetal goat tongue cell line for detection and isolation of foot-and-mouth disease virus","volume":"47","author":"Brehm","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0190","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0092-1157(85)80048-2","article-title":"An international collaborative study on foot and mouth disease virus assay methods 2 Quantification of 146S particles","volume":"13","author":"Doel","year":"1985","journal-title":"J Biol Stand"},{"key":"10.1016\/j.vaccine.2017.02.003_b0195","unstructured":"OIE. Manual of diagnostic tests and vaccines for terrestrial animals. Office Paris: International des Epizooties; 2012."},{"key":"10.1016\/j.vaccine.2017.02.003_b0200","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologischer reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Path u Pharmakol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0205","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1007\/s007050050390","article-title":"Differentiation of infection from vaccination in foot-and-mouth disease by the detection of anti-bodies to the non-structural proteins 3D, 3AB and 3ABC in ELISA using antigens expressed in baculovirus","volume":"143","author":"Sorensen","year":"1998","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virol.2014.11.023","article-title":"Foot-and-mouth disease vaccination induces cross-reactive IFN-\u03b3 responses in cattle that are dependent on the integrity of the 140S particles","volume":"476","author":"Bucafusco","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.02.003_b0215","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1128\/JVI.67.9.5139-5145.1993","article-title":"Genetically engineered foot-and-mouth disease viruses with poly(C) tracts of two nucleotides are virulent in mice","volume":"67","author":"Rieder","year":"1993","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2017.02.003_b0220","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.2460\/javma.2002.220.1636","article-title":"Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus","volume":"220","author":"Callahan","year":"2002","journal-title":"J Am Vet Med Assoc"},{"key":"10.1016\/j.vaccine.2017.02.003_b0225","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/CVI.00150-09","article-title":"Optimization of a whole-blood gamma interferon assay for detection of Mycobacterium bovis-infected cattle","volume":"16","author":"Schiller","year":"2009","journal-title":"Clin Vacc Immun"},{"key":"10.1016\/j.vaccine.2017.02.003_b0230","unstructured":"Lazarus DD, Burroughs R, van Schalkwyk L, Maree FF, Thomson GR, Fosgate GT. Vaccination and control of FMD in cattle at livestock-wildlife interface areas of the Kruger National Park South Africa. In: Conf proceedings. GFRA conference, Tanzania; 2013. p. 4."},{"key":"10.1016\/j.vaccine.2017.02.003_b0235","article-title":"Engineering structurally modified SAT2 viruses for increased thermostability","author":"Scott","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0240","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.vaccine.2008.01.038","article-title":"High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus","volume":"26","author":"Brehm","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0245","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0264-410X(02)00691-6","article-title":"Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines","volume":"21","author":"Cox","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.02.003_b0250","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1099\/0022-1317-79-7-1687","article-title":"Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse","volume":"79","author":"Barnett","year":"1998","journal-title":"J Gen Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17301664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,5]],"date-time":"2020-10-05T19:58:13Z","timestamp":1601927893000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17301664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":50,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0264410X17301664"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.003","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of immune responses of stabilised SAT2 antigens of foot-and-mouth disease in cattle","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}